<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01079208</url>
  </required_header>
  <id_info>
    <org_study_id>09.04.INF</org_study_id>
    <nct_id>NCT01079208</nct_id>
  </id_info>
  <brief_title>Growth of Infants Fed New Starter Formula</brief_title>
  <official_title>Assessment of Growth of Infants Fed Starter Formulas With Modified Protein and Synbiotics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the growth of infants fed a novel starter formula&#xD;
      containing synbiotics and different protein levels, compared to a standard starter infant&#xD;
      formula, during the first four months of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Breastfeeding represents the &quot;gold standard&quot; for infant health, and efforts are being made to&#xD;
      support breast feeding at both the international and local levels. After breast milk, infant&#xD;
      formulas are the next best source of nutrition for newborn and growing infants. Science and&#xD;
      industry are striving to develop formulas that mimic as close as possible the physiological&#xD;
      responses to human milk. There are a multitude of factors that make human milk the&#xD;
      physiologically ideal for the infant. Among these, two important factors are the level of&#xD;
      protein and the presence of pre-and probiotics in breast milk.&#xD;
&#xD;
      The purpose of this study will be to evaluate growth of healthy infants fed a partially&#xD;
      hydrolyzed whey protein formula with a level of protein closer to breast milk, with or&#xD;
      without synbiotics, during the first four months of life as compared to the growth of infants&#xD;
      fed a partially hydrolyzed whey protein formula with a standard protein level (standard&#xD;
      formula). Additionally, the infant's digestive tolerance of the starter formula and frequency&#xD;
      of morbidity will be investigated until 6 months of age.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight gain will be assessed in grams per day, in the period of 14 to 112 days of life (4 months)</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance, morbidity, protein status, metabolic markers</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">297</enrollment>
  <condition>Dietary Intervention</condition>
  <arm_group>
    <arm_group_label>standard starter infant formula</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>standard starter infant formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>test starter formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>test infant formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>test starter formula with synbiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>starter formula with synbiotics and adapted protein levels</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>test starter infant formula</intervention_name>
    <description>infants are fed for 6 months with this starter formula</description>
    <arm_group_label>test starter formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>test starter infant formula with synbiotics</intervention_name>
    <description>infant are fed for 6 months with this formula</description>
    <arm_group_label>test starter formula with synbiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control standard formula</intervention_name>
    <description>infant are fed 6 months with this formula</description>
    <arm_group_label>standard starter infant formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy newborn infant&#xD;
&#xD;
          -  Full-term (&gt; 37 weeks gestation)&#xD;
&#xD;
          -  Birth weight &gt; 2500 and &lt; 4500 g&#xD;
&#xD;
          -  14±3 days of age on enrollment&#xD;
&#xD;
          -  Singleton birth&#xD;
&#xD;
          -  Infant's mother has elected not to breastfeed prior to enrollment&#xD;
&#xD;
          -  Has not received solid foods&#xD;
&#xD;
          -  Having obtained his/her legal representative's informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known or suspected cow-milk allergy&#xD;
&#xD;
          -  Congenital illness or malformation that may affect infant feeding and/or growth&#xD;
&#xD;
          -  Significant prenatal and/or postnatal disease&#xD;
&#xD;
          -  Any readmission to hospital (except for hyperbilirubinemia) prior to enrollment&#xD;
&#xD;
          -  Receiving prescription medication (with exception of treatment for thrush) or frequent&#xD;
             use of over the counter medications except vitamin and mineral supplements&#xD;
&#xD;
          -  Has received oral or intravenous antibiotic therapy in the last 7 days&#xD;
&#xD;
          -  Has received probiotics in the last 7 days&#xD;
&#xD;
          -  Currently participating in another clinical study&#xD;
&#xD;
          -  Infant's family who in the Investigator's assessment cannot be expected to comply with&#xD;
             treatment (feeding regimen)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Cabana, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Health Policy Studies, University of California</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF Institute for Health Policy Studies/Pediatrics</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Institute for Clinical Research</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Children's Health Research Institute</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <study_first_submitted>March 2, 2010</study_first_submitted>
  <study_first_submitted_qc>March 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2010</study_first_posted>
  <last_update_submitted>December 2, 2014</last_update_submitted>
  <last_update_submitted_qc>December 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>infant formula, synbiotics, probiotics, nutrition</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

